ArticlePharmaceutics2022

Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies.

Doaa Jbara-Agbaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.